Clinical trial Recruiting at 1 site Interventional Ages 18 to 64

Loxoprofen Sodium Patch to Help Postoperative Pain After Laparoscopic Surgery

Official title: The Efficacy and Safety of Incisional Preemptive Analgesia Using Loxoprofen Sodium Patch in Patients Undergoing Laparoscopic Surgery: a Multi-center Randomized Controlled Trial.

Run by Beijing Tiantan Hospital · NCT07591207 · Data updated 2026-11-12

This study tests whether applying a Loxoprofen patch to the incision area can help reduce pain after laparoscopic gallbladder removal, appendix removal, or hernia repair.

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment134 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations2 sites (Beijing, Beijing Municipality and 1 other locations)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 31, 2027
Study endsMay 31, 2028
Registry record updatedJune 16, 2026
Trial IDNCT07591207 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-64 undergoing elective laparoscopic cholecystectomy, appendectomy, or hernia repair under general anesthesia, and meeting ASA I-III criteria.

Probably not a fit

Patients with contraindications to NSAIDs, severe BMI extremes, or those outside the eligible surgical procedures may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized trial investigates whether a Loxoprofen Sodium Patch used on the incision site can lessen postoperative pain in adults undergoing elective laparoscopic cholecystectomy, appendectomy, or hernia repair. Participants are adults 18-64 with ASA I-III and are randomized to receive the patch on the incision or on the opposite side, with the aim of reducing analgesic needs and side effects while improving satisfaction. The study focuses on local incision analgesia and its potential to minimize systemic analgesic requirements after surgery. Outcomes include pain levels, analgesic consumption, side effects, and patient satisfaction. The trial is conducted at Beijing Tiantan Hospital with a single lead sponsor and no listed collaborators.

Why it matters

Potential benefit: If successful, patients could experience less incision pain after laparoscopic surgery and require fewer pain medications.

How similar studies have gone: Previous studies have explored local analgesia strategies to reduce postoperative pain, with mixed results; this trial tests a specific patch approach in a defined surgical population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients scheduled for elective Laparoscopic Surgery for laparoscopic cholecystectomy, appendectomy, or hernia repair under general anesthesia;
2. Ages 18 to 64 years old
3. American Society of Anesthesiologists (ASA) physical status of I-III
4. Patients must be able to understand the nature and potential personal consequences of the clinical trial and cooperate with follow-up investigations
5. signing of the informed consent form.

Exclusion Criteria:

1. History of chronic pain syndrome of any cause and mental illness
2. Excessive alcohol or drug abuse, chronic opioid use (more than 2 weeks or 3 days per week for more than 1 month), use of drugs with confirmed or suspected sedative or analgesic effects, or use of any painkiller within 24 h before surgery.
3. History of hypertension (Grade 3, extremely high risk)
4. Pregnancy or breastfeeding.
5. Extreme body mass index (BMI) (\< 15 or \> 35).
6. Participation in another interventional trial that interferes with the intervention or outcome of this trial.
7. Digestive system diseases (such as peptic ulcers, gastric bleeding).
8. Patients with coronary artery disease.
9. Patients with renal impairment (serum creatinine \> 176 µmol/L) and abnormal liver function(alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) \> 2× the upper limit of normal (ULN) or total bilirubin (TBIL) ≥ 1.5×ULN).
10. Subjects with coagulation dysfunction (prothrombin time or activated partial thromboplastin time is higher than the normal threshold) or patients who are taking oral anticoagulants for other medical reasons and have not stopped it before surgery, such as warfarin or new anticoagulants rivaroxaban or dabigatran.
11. Patients with a history of allergy to anyone of the study drugs.

Where it's running

  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.